South Korea Predictive Biomarkers Market Size & Outlook

The predictive biomarkers market in South Korea is expected to reach a projected revenue of US$ 1,942.6 million by 2030. A compound annual growth rate of 20.2% is expected of South Korea predictive biomarkers market from 2025 to 2030.
Revenue, 2024 (US$M)
$665.5
Forecast, 2030 (US$M)
$1,942.6
CAGR, 2025 - 2030
20.2%
Report Coverage
South Korea

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea predictive biomarkers market, 2018-2030 (US$M)

South Korea predictive biomarkers market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Korea predictive biomarkers market highlights

  • The South Korea predictive biomarkers market generated a revenue of USD 665.5 million in 2024 and is expected to reach USD 1,942.6 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 20.2% from 2025 to 2030.
  • In terms of segment, cancer was the largest revenue generating indication in 2024.
  • Immunological Diseases is the most lucrative indication segment registering the fastest growth during the forecast period.


Predictive biomarkers market data book summary

Market revenue in 2024USD 665.5 million
Market revenue in 2030USD 1,942.6 million
Growth rate20.2% (CAGR from 2025 to 2030)
Largest segmentCancer
Fastest growing segmentImmunological Diseases
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Other


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.7% of the global predictive biomarkers market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan predictive biomarkers market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,924.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Predictive Biomarkers Market Companies

Name Profile # Employees HQ Website
PacBio View profile 501-1000 Menlo Park, California, United States, North America https://www.pacb.com
Genomic Health View profile 501-1000 Redwood City, California, United States, North America http://www.genomichealth.com
F. Hoffmann-La Roche Ltd. View profile - - -
PerkinElmer View profile 10001+ Waltham, Massachusetts, United States, North America http://www.perkinelmer.com
Bio-Techne Corp View profile 3050 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 https://www.bio-techne.com
Myriad Genetics Inc View profile 2700 320 Wakara Way, Salt Lake City, UT, United States, 84108 https://www.myriad.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Becton Dickinson & Co View profile 73000 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 https://www.bd.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

South Korea predictive biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to predictive biomarkers market will help companies and investors design strategic landscapes.


Cancer was the largest segment with a revenue share of 43.07% in 2024. Horizon Databook has segmented the South Korea predictive biomarkers market based on cancer, cardiovascular diseases, neurological diseases, immunological diseases, other covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to South Korea predictive biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea predictive biomarkers market databook

  • Our clientele includes a mix of predictive biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea predictive biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into South Korea predictive biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea predictive biomarkers market size, by indication, 2018-2030 (US$M)

South Korea Predictive Biomarkers Market Outlook Share, 2024 & 2030 (US$M)

South Korea predictive biomarkers market size, by indication, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online